Expertise in
5
conditions

Jee H. Roh

Seoul, KR 
Expertise in
5
conditions
Seoul, KR 

Overview

Jee Roh practices practicing medicine in Seoul, Republic of Korea.

Roh is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Alzheimer's Disease, Dementia, Frontotemporal Dementia, and Vascular Dementia.

They are actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 4 clinical trials.

Locations

Seoul, Republic of Korea
Other Locations
Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjectives With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease
Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjectives With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease
Enrollment Status: Completed
Publish Date: September 06, 2023
Intervention Type: Drug
Study Drug: 18F PI-2620
Study Phase: Phase 2
Clinical Evaluation of [18F]PI-2620 Positron Emission Computed Tomography for Imaging Tau Protein in Patients With Tauopathies and Healthy Volunteers: Phase 0 Study
Clinical Evaluation of [18F]PI-2620 Positron Emission Computed Tomography for Imaging Tau Protein in Patients With Tauopathies and Healthy Volunteers: Phase 0 Study
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Drug
Study Phase: Early Phase 1
An Open Label, Multicenter Study for Evaluation of the Clinical Utility of [18F]THK-5351 Positron Emission Computed Tomography in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, Subjects With Alzheimer's Disease and Subjects With Other Neurodegenerative Diseases
An Open Label, Multicenter Study for Evaluation of the Clinical Utility of [18F]THK-5351 Positron Emission Computed Tomography in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, Subjects With Alzheimer's Disease and Subjects With Other Neurodegenerative Diseases
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase I [18F]THK-5351 Positron Emission Computed Tomography Study of Biodistribution, Pharmacokinetics and Safety in Cognitively Healthy Subjects and Patients With Alzheimer's Disease
A Phase I [18F]THK-5351 Positron Emission Computed Tomography Study of Biodistribution, Pharmacokinetics and Safety in Cognitively Healthy Subjects and Patients With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: December 14, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

77 Total Publications

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.
Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026

Frequently Asked Questions about Jee H. Roh

Is Jee H. Roh a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jee H. Roh is classified as an Distinguished expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jee H. Roh participate in research or clinical trials?

Yes. Jee H. Roh has published 77 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Jee H. Roh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Roh's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile